Trade Bristol Myers ^BMY

Lazard Asset Management LLC Raises Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb (BMY) to Post Earnings on Thursday - Markets Daily

Bristol Myers Squibb (NYSE:BMY) Sets New 1-Year High - Here's Why

Bristol Myers Squibb launches Relopduo, its fixed-dose combination for skin cancer, in India

CIBC Appoints Mohit Dhingra as New CEO for India Operations, ETGCC

Bristol Myers Squibb (NYSE:BMY) Reaches New 52-Week High - Should You Buy? - Stock Observer

BMS launches dual immunotherapy for metastatic melanoma

Orbimed Advisors LLC Acquires 150,000 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Purchased by OMERS ADMINISTRATION Corp

Renaissance Technologies LLC Sells 1,376,638 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Renaissance Technologies LLC Lowers Stock Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Launches Revolutionary Onco-Derma Therapy Relopduo in India for Melanoma Treatment, ETPharma

Healthcare of Ontario Pension Plan Trust Fund Acquires 286,833 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Orbimed Advisors LLC Buys 150,000 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Weiss Asset Management LP Buys Shares of 38,094 Bristol Myers Squibb Company $BMY - Daily Political

Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial

Agilent Technologies (A) Is Up 5.4% After New OPDIVO-Linked PD-L1 Test Approval - Has The Bull Case Changed?

Hilltop Holdings Inc. Cuts Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Holdings Lowered by Dai ichi Life Insurance Company Ltd

Bristol Myers Squibb Company $BMY Shares Sold by Gabelli Funds LLC

Hilltop Holdings Inc. Lowers Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Best Pharmaceutical Stocks To Watch Now - July 25th

Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test

Bristol Myers Squibb Company $BMY Shares Purchased by GC Wealth Management RIA LLC

Entropy Technologies LP Sells 164,892 Shares of Bristol Myers Squibb Company $BMY

Cannell & Spears LLC Has $14.71 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Epoch Investment Partners Inc. Increases Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Johnson & Johnson (JNJ) Reports Early Phase 3 Win In Multiple Myeloma

3 Healthcare Stocks We Keep Off Our Radar

Knott David M Jr Sells 8,378 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Sold by Knott David M Jr

Oak Associates Ltd. OH Acquires New Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Stake Raised by Sei Investments Co.

Compound Planning Inc. Has $4.94 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily

Compound Planning Inc. Has $4.94 Million Holdings in Bristol Myers Squibb Company $BMY

Johnson And Johnson Stock And Other Defensive Dividend Picks For Uncertain Markets

Merck (MRK) Gets Fresh KEYTRUDA Momentum In EU Testing And Biliary Cancer Trials

KCM Capital Inc Invests $3.99 Million in Bristol Myers Squibb Company $BMY - Stock Observer

Measured Wealth Private Client Group LLC Purchases 18,842 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Advancing antibody drug conjugates in gastrointestinal cancers

Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials

Bank of America Says the Fed Should Raise Rates Now: 4 Dividend Inflation-Resistant Stocks

Bristol Myers Squibb (BMY) Wins FDA Filing And Nvidia Tie Up, Is It Still Undervalued?

First Trust Advisors LP Raises Position in Bristol Myers Squibb Company $BMY

Bellwether Advisors LLC Purchases New Shares in Bristol Myers Squibb Company $BMY

Alexandria Real Estate Equities (ARE) Delivers 427,000 RSF Bristol Myers Squibb R And D Hub

Westpac Banking Corp Has $11.68 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Novartis (SWX:NOVN) Is Pushing AI Deeper Into Drug Discovery

Bellwether Advisors LLC Acquires New Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells

Independent Financial Group LLC Invests $976,000 in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Acquires Nvidia's Advanced AI System for Faster Drug Discovery, ETManufacturing

Bristol Myers Squibb Company $BMY Shares Bought by Meeder Asset Management Inc. - Stock Observer

HORAN Wealth LLC Grows Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Erste Group Bank Has Positive Outlook of BMY FY2026 Earnings - Stock Observer

Epicardial adipose tissue thickness is associated with circulating biomarkers in individuals without known cardiac disease across a broad adiposity spectrum

Bristol Myers Expands NVIDIA Partnership to Build Top Life Sciences AI Supercomputer

Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory

Bristol Myers Squibb (BMY) Doubles Down on Nvidia (NVDA) AI Tech for Drug Development

Nvidia partners with Bristol-Myers Squibb to build AI supercomputer for drug discovery

Bristol Myers buys Nvidia's latest AI computing system for drug research

Pharmaceutical Stocks To Research - July 20th - Daily Political

Bristol Myers (BMY) Is Up 5.5% After FDA Accepts Mezigdomide NDA In Multiple Myeloma

Swiss National Bank Raises Stock Position in Bristol Myers Squibb Company $BMY - Markets Daily

SEB Asset Management AB Takes Position in Bristol Myers Squibb Company $BMY

Mediolanum International Funds Ltd Has $82.85 Million Holdings in Bristol Myers Squibb Company $BMY

Swiss National Bank Purchases 396,700 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

FDA-Approved PD-L1 Test for GI Cancers Could Be A Game Changer For Agilent Technologies (A)

Hillsdale Investment Management Inc. Has $101,000 Holdings in Bristol Myers Squibb Company $BMY

California Public Employees Retirement System Purchases 121,813 Shares of Bristol Myers Squibb Company $BMY

Allspring Global Investments Holdings LLC Boosts Stake in Bristol Myers Squibb Company $BMY

SteelPeak Wealth LLC Has $1.62 Million Stock Position in Bristol Myers Squibb Company $BMY - Daily Political

Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis

Bristol Myers Squibb Company $BMY Shares Purchased by Geneos Wealth Management Inc. - Markets Daily

Is Bristol-Myers Squibb (BMY) Reasonable After Its 32% Run?

Aware Super Pty Ltd as trustee of Aware Super Purchases New Shares in Bristol Myers Squibb Company $BMY - Daily Political

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Investors Purchase High Volume of Call Options on Bristol Myers Squibb (NYSE:BMY) - Zolmax

Investors Buy Large Volume of Bristol Myers Squibb Call Options (NYSE:BMY)

Illinois Municipal Retirement Fund Sells 87,210 Shares of Bristol Myers Squibb Company $BMY

Bank of New York Mellon Corp Sells 1,194,538 Shares of Bristol Myers Squibb Company $BMY

Response kinetics and depth of response after idecabtagene vicleucel in relapsed/refractory multiple myeloma

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada | Morningstar

Diversify Wealth Management LLC Acquires 21,775 Shares of Bristol Myers Squibb Company $BMY

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada | Valuespectrum.com

Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 - Data Talk | Morningstar

Bristol Myers Squibb (BMY) Following FDA Acceptance Has An Undervalued Case

Juvenile Idiopathic Arthritis Market is Forecast to Grow at a 4.6% CAGR from 2026 to 2036 As Biologics, JAK Inhibitors, and Emerging Targeted Therapies Reshape Pediatric Arthritis Treatment.

Real-world treatment patterns, healthcare resource utilization and economic burden in U.S. adults with schizophrenia with and without tardive dyskinesia

Single-cell transcriptome reveals keratinocyte subclusters contributing to altered differentiation and inflammatory responses in atopic dermatitis

Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight

Bristol Myers Wins FDA Review of Mezigdomide in Multiple Myeloma | Morningstar